Insufficient scRNA-seq data for expression of TDRD1 at single-cell level.
Insufficient scRNA-seq data for expression of TDRD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 69% | 12.38 | 170 / 245 | 74% | 14.59 | 372 / 502 |
breast | 97% | 42.78 | 444 / 459 | 23% | 2.84 | 258 / 1118 |
pancreas | 97% | 49.74 | 318 / 328 | 10% | 0.50 | 18 / 178 |
spleen | 100% | 66.17 | 241 / 241 | 0% | 0 | 0 / 0 |
ovary | 96% | 46.92 | 172 / 180 | 3% | 0.28 | 11 / 430 |
heart | 96% | 43.96 | 828 / 861 | 0% | 0 | 0 / 0 |
thymus | 86% | 15.79 | 560 / 653 | 1% | 0.03 | 4 / 605 |
stomach | 74% | 20.38 | 266 / 359 | 8% | 0.81 | 24 / 286 |
adipose | 81% | 17.07 | 978 / 1204 | 0% | 0 | 0 / 0 |
intestine | 76% | 17.84 | 732 / 966 | 5% | 0.48 | 24 / 527 |
kidney | 72% | 22.76 | 64 / 89 | 7% | 0.54 | 59 / 901 |
bladder | 71% | 11.33 | 15 / 21 | 3% | 0.39 | 14 / 504 |
esophagus | 64% | 14.16 | 929 / 1445 | 9% | 1.20 | 17 / 183 |
uterus | 68% | 13.47 | 115 / 170 | 3% | 0.38 | 15 / 459 |
brain | 70% | 12.75 | 1839 / 2642 | 1% | 0.02 | 4 / 705 |
blood vessel | 65% | 19.62 | 869 / 1335 | 0% | 0 | 0 / 0 |
liver | 54% | 11.22 | 122 / 226 | 6% | 0.27 | 23 / 406 |
lung | 50% | 7.15 | 289 / 578 | 9% | 0.97 | 102 / 1155 |
muscle | 48% | 7.25 | 389 / 803 | 0% | 0 | 0 / 0 |
skin | 47% | 11.72 | 849 / 1809 | 1% | 0.20 | 6 / 472 |
adrenal gland | 43% | 10.26 | 110 / 258 | 3% | 0.16 | 7 / 230 |
peripheral blood | 12% | 7.39 | 109 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.21 | 6 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.52 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0007283 | Biological process | spermatogenesis |
GO_0030719 | Biological process | P granule organization |
GO_0007281 | Biological process | germ cell development |
GO_0141007 | Biological process | siRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0034587 | Biological process | piRNA processing |
GO_0071546 | Cellular component | pi-body |
GO_0033391 | Cellular component | chromatoid body |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0045202 | Cellular component | synapse |
GO_0043186 | Cellular component | P granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TDRD1 |
Protein name | Tudor domain containing 1 Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1) |
Synonyms | |
Description | FUNCTION: Plays a central role during spermatogenesis by participating in the repression transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Required for the localization of Piwi proteins to the meiotic nuage. Involved in the piRNA metabolic process by ensuring the entry of correct transcripts into the normal piRNA pool and limiting the entry of cellular transcripts into the piRNA pathway. May act by allowing the recruitment of piRNA biogenesis or loading factors that ensure the correct entry of transcripts and piRNAs into Piwi proteins (By similarity). . |
Accessions | ENST00000369280.1 ENST00000695399.1 [Q9BXT4-1] ENST00000251864.7 [Q9BXT4-3] H9KV62 Q9BXT4 H9KV63 ENST00000369282.5 |